Handelsbanken Fonder’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,146
| Closed | -$27K | – | 1623 |
|
|
2023
Q1 | $27K | Hold |
15,146
| – | – | ﹤0.01% | 1560 |
|
|
2022
Q4 | $48K | Buy |
+15,146
| New | +$48K | ﹤0.01% | 1549 |
|
|
2022
Q3 | – | Sell |
-28,246
| Closed | -$117K | – | 1591 |
|
|
2022
Q2 | $117K | Sell |
28,246
-7,000
| -20% | -$29K | ﹤0.01% | 1569 |
|
|
2022
Q1 | $205K | Hold |
35,246
| – | – | ﹤0.01% | 1628 |
|
|
2021
Q4 | $264K | Hold |
35,246
| – | – | ﹤0.01% | 1643 |
|
|
2021
Q3 | $318K | Hold |
35,246
| – | – | ﹤0.01% | 1573 |
|
|
2021
Q2 | $422K | Buy |
35,246
+17,800
| +102% | +$213K | ﹤0.01% | 1499 |
|
|
2021
Q1 | $219K | Hold |
17,446
| – | – | ﹤0.01% | 1528 |
|
|
2020
Q4 | $272K | Hold |
17,446
| – | – | ﹤0.01% | 1446 |
|
|
2020
Q3 | $165K | Hold |
17,446
| – | – | ﹤0.01% | 1413 |
|
|
2020
Q2 | $156K | Buy |
+17,446
| New | +$156K | ﹤0.01% | 1404 |
|
|
2019
Q2 | – | Sell |
-95,000
| Closed | -$906K | – | 193 |
|
|
2019
Q1 | $906K | Hold |
95,000
| – | – | 0.02% | 173 |
|
|
2018
Q4 | $1.09M | Sell |
95,000
-450,000
| -83% | -$5.17M | 0.02% | 159 |
|
|
2018
Q3 | $9.24M | Buy |
545,000
+188,000
| +53% | +$3.19M | 0.17% | 131 |
|
|
2018
Q2 | $5.07M | Buy |
+357,000
| New | +$5.07M | 0.1% | 145 |
|